First Page | Document Content | |
---|---|---|
Date: 2013-06-27 13:51:08 | NOVEN ANNOUNCES COMMENCEMENT OF PHASE 2 STUDY OF INVESTIGATIONAL d-AMPHETAMINE TRANSDERMAL SYSTEM FOR ADHD October 2, 2012 − Miami, FL and New York, NY − Noven Pharmaceuticals, Inc., a whollyowned subsidiary of HisamAdd to Reading ListSource URL: www.noven.comDownload Document from Source WebsiteFile Size: 170,49 KBShare Document on Facebook |